599.5000 -9.05 (-1.49%)
NSE Jun 15, 2026 12:59 PM
Volume: 167.6K
 

599.50
-1.49%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. is trading above all available SMAs
More from Solara Active Pharma Sciences Ltd.
Recommended